Static Chart CellaVision AB

Stocks

Market Closed - Nasdaq Stockholm 12:00:00 2026-10-16 EDT			5-day change	1st Jan Change
168.40 ^SEK	+1.08%		+4.08%	+7.12%

10-13	DNB Carnegie raises price target for Cellavision to SEK 185 (180), reiterates buy	FW
10-12	Lannebo Health and New Technology fell 0.5 percent in September, FDA approval lifted Egetis Therapeutics	FW

Duration

Period